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Site-directed mutagenesis  of  the  Na,K-ATPase  has 
provided  a  rational  approach  to identify several amino 
acids  that  appear  to  be  involved  in  ouabain sensitivity. 
In  order  to identify  additional  amino  acids  that  play  a 
role  in  ouabain  binding, we used  formic  acid to ran- 
domly mutagenize a cDNA cassette encoding amino 
acids 691-946 of the  sheep  Na,K-ATPase a subunit. 
This was then used to replace the wild type cDNA 
cassette in  the full-length cDNA,  and  pools of mutants 
were electroporated  into HeLa cells. Ouabain-resistant 
cells were selected  in 0.5 FM ouabain,  and  the  polym- 
erase chain  reaction was used to amplify  the  region 
corresponding to the mutagenized cassette from the 
genomic DNA  of  the resistant cells. Sequence analysis 
of the polymerase chain reaction product revealed a 
single amino acid substitution, T797N. Site-directed 
mutagenesis was used  to  reproduce this change  in  the 
wild  type  sheep a subunit,  and this construct was able 
to confer  resistance  to HeLa cells, verifying the  role  of 
the  mutation  in  ouabain resistance. The  mutant  sheep 
enzyme was found  to  be as resistant  to  ouabain as is 
the  rat  Na,K-ATPase.  These  data  suggest  that T797N, 
predicted to be in the fifth putative transmembrane 
domain, is involved  in  the  interaction between ouabain 
and  the  Na,K-ATPase. 
Na,K-ATPase is a membrane-bound enzyme found in all 
eukaryotes and is critical in  maintaining the electrochemical 
gradient across the cell membrane. It exists  as  a noncovalently 
linked heterodimer with a larger a subunit (100 kDa) and a 
smaller, glycosylated p subunit (35-50 kDa). The latter may 
assist in targeting the a subunit to  the xtracellular membrane 
(Geering, 1991) and may also modulate response to extracel- 
lular potassium (Jaisser et al., 1992). The a subunit  has been 
described as  the catalytic subunit  and is thought to contain 
most, if not all, of the binding site for a pharmacologically 
important group of drugs, the cardiac glycosides, which are 
used to  treat congestive heart failure. In view  of the pharma- 
cological  significance of cardiac glycosides, we are  interested 
in characterizing the ouabain binding site of the Na,K- 
ATPase. 
Most investigations of the ouabain binding site to  date have 
focused on the amino-terminal half of the enzyme. Price  and 
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Lingrel (1988) used chimeras between the ouabain-resistant 
rat a1 isozyme and  the ouabain-sensitive sheep a1 and found 
that  the amino-terminal half of the  rat protein  contained the 
determinants of ouabain resistance. It was subsequently 
shown that residues R113 and D124,  which lie on the border 
of the putative Hl-H2 extracellular domain of the rat a 
subunit, were responsible for the ouabain-resistant  nature of 
the rodent enzyme. If the corresponding border residues in 
the sheep a1 subunit were replaced with charged amino acids, 
either individually or in pairs, these changes alone were 
sufficient to confer ouabain resistance (Price et al., 1990). 
This group also found that when a conserved amino acid, 
Asp-121,  was replaced with alanine, glutamic acid, or serine 
these changes could confer resistance to ouabain (Price et al., 
1989). Subsequent studies  demonstrated that, while the H1- 
H2 domain is involved in ouabain binding, this region  does 
not  interact with the sugar moiety of the inhibitor (O’Brien 
et al., 1993). Interestingly,  mutations  in the first  transmem- 
brane domain, H1, have been shown to generate an ouabain- 
resistant enzyme. These include the mutations C113Y and 
C113F in the dog a subunit (Canessa et al., 1992) and the 
analogous mutants C104A,  C104F of the sheep a1 enzyme, as 
well as Y108A in  the sheep enzyme (Schultheis and Lingrel 
1993). 
Although the above findings show strong evidence for the 
importance of the putative H1 transmembrane domain and 
the Hl-H2 extracellular domain in ouabain inhibition, the 
potential involvement of residues from other regions cannot 
be ignored. This is supported, in  part, by the finding that a 
monoclonal antibody, localized to the Hl-H2 extracellular 
domain, was found to increase ouabain binding (Arystarkhova 
et al., 1992). If the Hl-H2 extracellular domain of the a 
subunit was the only region that confers sensitivity to oua- 
bain, at least  partial occlusion  of the H1-H2 domain by an 
antibody would  be expected to decrease, rather  than increase, 
ouabain binding. Since this is not  the case, it is reasonable to 
assume that the ouabain binding site may also consist of 
residues in several other extracellular or  transmembrane do- 
mains. 
Based on the hypothesis that other extracellular or trans- 
membrane domains of this  protein may  be  involved in con- 
ferring ouabain resistance, we have used random mutagenesis 
to investigate a region of the a subunit that has not been 
extensively studied and includes amino acids 691-946. This 
region encompasses the putative  transmembrane domains H5 
and H6, a cytoplasmic region and  a large predicted extracel- 
lular domain. 
EXPERIMENTAL  PROCEDURES 
Materiak-Tissue culture supplies were obtained from Life Tech- 
nologies, Inc. and the Lineberger Cancer Center Tissue Culture 
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Facility at   the University of North Carolina. Molecular biology re- 
agents were from Promega,  Boehringer-Mannheim.  Amersham Corp., 
Qiagen, Stratagene,  and U. S. Biochemical Corp. Ouabain and NADH 
were obtained from Boehringer-Mannheim. Phosphoenolpyruvate, 
lactate dehydrogenase, pyruvate  kinase, and  ATP were from Sigma. 
Bio-Rad was the source for electroporation equipment. All other 
reagents were of the highest  quality available. The eukaryotic  expres- 
sion vector constructs have been described previously (Price and 
Lingrel, 1988). Briefly, the vector, pKC4, has cDNA inserts of either 
rat a1 (rat  al-pKC4)  or sheep a1 (S a1-pKC4)  Na,K-ATPase  sub- 
units. The sheep a1 cDNA was divided by endonuclease  restriction 
sites  into discrete  cassettes that  are compatible  with the M13  multiple 
cloning site. 
Random Mutagenesis-Site-directed mutagenesis was used to 
change  base 2355 from C to T in  the  sheep a1 cDNA. This  created a 
unique HindIII  site  without changing the  amino acid sequence of the 
protein. This restriction site together  with  a BglII site downstream 
created  a 763-bp’ cassette that codes for amino acids 691-946 in the 
sheep a1 cDNA. This  cassette was excised using HindIII  and BglII 
and inserted into  the  HindIII/BamHI  site of  M13. Mutagenesis was 
used to recreate the BglII site in the M13 construct. The single- 
stranded M13 was treated with 10.6 M formic  acid for 2  min a t  room 
temperature. The phage were then  ethanol-precipitated,  and double- 
stranded DNA was produced by annealing  the M13  universal  sequenc- 
ing  primer and elongating  with reverse transcriptase  in  the presence 
of 10 mM of each of the four deoxynucleotide triphosphates. The 
mutagenized cassettes were excised from the double-stranded phage 
by digestion with HindIII  and BglII. The pool of mutant  cassettes 
was used to replace the wild type cassette in Sal-pKC4 that had 
likewise been digested with HindIII  and BglII. 
Cell Culture and Transfection-HeLa cells were grown in Dulbec- 
CO’S modified Eagle’s medium supplemented with 10% bovine calf 
serum and antibiotics. Cells were prepared for electroporation by mild 
trypsinization followed by a wash with media and  then a wash in 
phosphate-buffered sucrose. Cells were suspended in phosphate-buff- 
ered sucrose at  a  concentration of 2.5 X lo6 cells/ml in  preparation 
for electroporation. The pKC4 vector containing  the pool of mutants 
was linearized using the restriction  endonuclease  ScaI. After phenol/ 
chloroform extraction and  ethanol precipitation, the pool of mutant 
plasmids was suspended in phosphate-buffered  sucrose at  a  concen- 
tration of 50 pglml. Cells and DNA were mixed in equal volumes 
(400 pl) and incubated at  room temperature for 2  min. This mixture 
was electroporated a t  350 V, 25 microfarads. The cells were trans- 
ferred to a 100-mm tissue culture dish and left a t  room temperature 
for 10 min before adding 10 ml of media. After 24 h, the media were 
replaced with  fresh media containing 0.5 p~ ouabain. Thereafter,  the 
media were replaced with fresh media containing ouabain every 2 
days. A total of 1 mg of pooled mutant plasmid was transfected  into 
a total of 5 X lo7 cells in 50 separate electroporations that were plated 
onto 50 initial 100-mm tissue culture plates. Resistant cells were 
isolated using  a  cloning cylinder and  the cell line  expanded in media 
containing 0.5 p M  ouabain. 
PCR and Sequencing-Genomic DNA was prepared for amplifica- 
tion essentially as described by Higuchi (1989). Briefly, cells were 
subject to mild trypsinization and washed twice with phosphate- 
buffered saline. Cells were resuspended to give  1.5 X lo7 cells/ml in 
a buffer containing 60 pg/ml Proteinase K, 50 mM KCl,  10 mM Tris- 
HCl, 2.5 mM  MgC12, 0.1 mg/ml gelatin, 0.45% Nonidet P-40, and 
0.45% Tween 20. The solution was incubated a t  55  “C for 1 h, followed 
by a 95  “C incubation for 10 min. Each  PCR reaction  used  approxi- 
mately 1 pg of genomic DNA as template. The negative  control was 
deionized distilled water. The positive control was the Sal-pKC4 
plasmid. Two oligonucleotide primers were designed to include the 
HindIII  and BglII restriction enzyme sites flanking the  cassette of 
interest. The forward primer was 5’AAGTACCACACGGAGATT- 
GTGTTC3’  and  the reverse primer was 5’GAAAGCAGCAAGGGC- 
TGTCTCTTC3’.  Both  primers were used at  a concentration of 20 
pmo1/100 pl reaction volume. The  concentration of dNTPs was 0.1 
mM. Amplification was performed on  an  Eri-Comp Twin-Bloc and 
consisted of an initial denaturation (94 “C for 7 min) when Taq 
polymerase was added, followed by 1 min at  50 “C  and 1 min at  70 “C. 
30 cycles of denaturation (94 “C for 1 min),  annealing (50 “C for 1 
min),  and elongation (70 “C for 4 min) followed. The  PCR product 
was size-fractionated by electrophoresis on a 1% agarose gel and  then 
excised and gel-purified with the Qiaex gel extraction kit (Qiagen). 
The abbreviations used are: bp, base pair(s); PCR, polymerase 
chain reaction. 
The purified PCR fragment (780 bp) was digested with  HindIII and 
BglII and  inserted  into  the  HindIII/BamHI  site of M13 for sequenc- 
ing. 5 plaques from 3 separate PCR reactions were sequenced to 
compensate for possible errors introduced by Taq polymerase. Se- 
quencing was performed  using the Sanger et al. (1977) dideoxy method 
with  Sequenase 2.0” from U. S. Biochemical. 
Site-directed Mutagenesis-Mutagenesis of the 763-bp cassette was 
performed  according to  the method of Kunkel (1985) as previously 
described (Price  and Lingrel, 1988). An oligonucleotide was designed 
to change the base a t  2669 from C to A to reproduce the T797N 
mutation when annealed to single-stranded M13 containing the 
HindIII/BglII  cassette.  Several  plaques were picked and sequenced, 
and  those  cassettes with the  mutation were sequenced in their  en- 
tirety.  Double-stranded (rf) form of the  mutant cassette in M13 was 
double-digested with HindIII  and BglII and ligated back into  the Sal- 
pKC4 that had likewise been double-digested. DH5aF’ cells were 
transformed, and several colonies were screened using restriction 
endonuclease digests. Positive colonies were sequenced in their  en- 
tirety before being purified by cesium chloride  gradient in preparation 
for electroporation into wild type  HeLa cells. 
Preparation of Crude Plasma Membranes  from HeLa Cells-”em- 
branes were prepared from untransfected  HeLa cells and cells trans- 
fected with  T797N mutants  or  rat al. This was done  essentially as 
described by Price and Lingrel (1988) except that cells from five 
confluent T150 flasks were harvested, and cells were homogenized 
using 70 strokes of a  Dounce-type homogenizer. Protein yields were 
determined  using the method of Bradford (1976). using bovine serum 
albumin as the standard. Microsome preparations were stored in 
liquid nitrogen and used  within  3 days. 
Na,K-ATPase Actiuity Assay-The spectrophotometric  assay  is an 
enzyme-linked  assay based on  that described by Schwartz et al. (1969). 
The assay preparations were incubated for 5 min before initiating 
readings. Activity was measured 20-25 min after membranes were 
added to  the assay  solutions containing ouabain.  Na,K-ATPase  activ- 
ity was determined by subtracting  the activity in a  Na+-free  assay 
from the  Na+-containing assays. Percent activity was determined by 
setting  the activity from an assay containing no ouabain to 100%. 
The results were plotted and  the ICs0 was determined from the graph. 
RESULTS AND DISCUSSION 
The pool of mutated cDNAs resulted in one resistant clone 
when transfected cells were selected in 0.5 PM ouabain. This 
clone, designated “Fl,” was expanded into a  stable cell line 
and maintained  in 0.5 PM ouabain. Genomic DNA  was isolated 
from F1 cells, and  PCR was used to amplify the integrated, 
randomly mutated cassette. Recovery of the relevant sequence 
from the genomic DNA using PCR (Fig. 1) shows a  band that 
is the same size (780 bp)  as  that produced when using the 
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FIG. 1. PCR products resolved on a 1% agarose gel. Genomic 
DNA was isolated from HeLa cells resistant  to 0.5 PM ouabain and 
used as a template for PCR amplification  (see  “Experimental Proce- 
dures”). Lane I, water only; lane 2, F1 genomic DNA; lane 3, sheep 
CY-1 pKC4. 
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that if the endogenous Na,K-ATPase gene  from HeLa genome 
was targeted, a significantly larger band would  be seen, since 
introns would  be included in the PCR product. This was not 
evident (Fig. 1). The PCR product recovered from F1 genomic 
DNA  is, in all probability, a result of the stable integration of 
the randomly mutagenized S al- pKC4 into the host genome 
and  that  the resistant phenotype is due to  the presence and 
expression of the  mutant sheep al-cDNA. 
Subsequent sequencing of the PCR product, subcloned into 
M13, revealed a single base pair change from C to A that 
conferred a T797N amino acid change (Fig. 2). After identi- 
fication of the  mutated base, site-directed mutagenesis was 
conducted to reproduce the mutation  in the wild type sheep 
al-cDNA. The mutation was then verified by sequencing, and 
the site-directed mutant was electroporated into HeLa cells. 
Resistant colonies were produced, verifying the significance 
of this residue in mediating ouabain resistance and that  the 
resistance observed in F1 cells is  not due to some anomalous 
factor(s). Crude membranes from these cells were prepared 
and assayed for the presence of ouabain resistant Na,K- 
ATPase activity (Fig. 3). This figure clearly indicates that 
two populations of Na,K-ATPase  are  in the cell membrane 
preparations with one inflection point of the curve represent- 
ing the inhibition of the wild type enzyme and  the second a 
more resistant,  mutant sodium pump (ICso approximately 3 
X lo-’ M). The  mutant was found to be as  resistant to ouabain 
Amino Acid # 793 801 
aminoacid L P L G T V T C I 
Sheep a-1 CTC CCC CTG GGG ACC GTC ATC CTC TGC 
F1 clone CTC CCC CTG GGG &C GTC ATC  CTC  TGC 
amino acid - N
FIG. 2. Amino acid sequence comparisons of the wild type 
sheep a1 and the F1 mutant clone. Sequencing was done using 
the dideoxy method with both dG and dI reactions for five plaques 
from each of three  separate PCR reactions (see “Experimental Pro- 
cedures”). Amino acid numbering is based on that of Shull et al. 
(1985). 
T 
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FIG. 3. Na,K-ATPase activity inhibited by ouabain. Mem- 
branes were prepared from wild type HeLa cells and clones trans- 
fected with site-directed mutants as described  under “Experimental 
Procedures.” Each data point used 10  pg  of protein. All values were 
corrected for background activity measured in a Na+- free assay. 
Percent activity was  determined  by setting the activity in the ouabain- 
free assay to 100%. 0, wild type HeLa; ., rat al; A, T797N-1; V, 
T797N-2. The specific Na,K-ATPase activity (pmol of ATP hydro- 
lyzed per mg of protein/h) of each microsome preparation in the 
absence of ouabain  was as follows: wild type HeLa = 41.6 & 2.63, n 
= 4; rat a1 = 71.77, n = 2; T797N-1 = 24.44; T797N-2 = 23.69. Plots 
for mutants are representative  of  two assays from two separate 
microsome  preparations. 
as  the Na,K-ATPase from HeLa cells expressing the  rat a1 
subunit. 
Threonine 797 is conserved in all species and isoforms 
reported to date (Lingrel et aL, 1990; Verrey et al., 1989; 
Jaisser et al., 1992), which supports  the possibility that  this 
residue has some functional role. Resistance to ouabain when 
this residue alone is  mutated suggests that this role includes 
an involvement between ouabain inhibition and threonine 
797. The substitution of asparagine for threonine is conserv- 
ative, as both  are polar uncharged residues with asparagine 
being  only slightly larger than threonine. Since major confor- 
mational differences with this T797N substitution are likely 
to be minimal, the specific  role of the side chain of T797 is 
emphasized. Additional amino acid mutations at  this position 
will aid  in the elucidation of the role that  this residue  plays, 
including whether or not T797 interacts directly with the 
glycoside. Interestingly, although Thr-797 is predicted to be 
in the intra-membrane region, it is thought  to lie  close to  the 
extracellular surface (Shull et al., 1985). If so, this together 
with the amphipathic  nature of the glycoside  would increase 
the possibility of interaction between Thr-797 and ouabain. 
It is possible that there is no direct interaction between 
threonine and ouabain. Resistance could be due to confor- 
mational shifts  in the protein that displace amino acids  from 
their normal interactions with ouabain. This could occur 
through a disrupted structure immediately surrounding the 
substituted amino acid and affect only a few residues. Alter- 
natively, the relative position the H5 transmembrane domain 
or  other  transmembrane domains may be tilted or otherwise 
disturbed through altered interactions between the substi- 
tuted residue and residues in juxtaposed transmembrane do- 
mains. 
Another possibility is that  the affinity between the sodium 
pump and Na’ or K+ has been changed by this substitution. 
Increased affinity between the pump for either or both ions 
may result in a more active pump and could compensate for 
inhibition by ouabain. Alternatively, the conformational 
change that accompanies the catalytic cycle  may  occur  more 
readily, even in the presence of ouabain. It must be stressed, 
however, that since the cells do survive in the presence of 
ouabain, the T797N mutant  is  a functional sodium pump, and 
any conformational shifts  are likely  be limited or localized. 
Medford et al. (1991)  have  shown that dog a1 isoform Na,K- 
ATPase truncated  after residue 554, just  past  the  ATP binding 
site, is expressed in vascular smooth muscle. T797N would 
not be included in such a protein, but, if T797 is involved in 
ouabain binding, the  truncated pump would  be expected to be 
more resistant  to ouabain than  the full-length enzyme. Since 
the truncated enzyme  seems to be a functional protein (Zhao 
et al., 1993), expression of the  truncated protein may be one 
mechanism to physiologically regulate sodium pump activity 
in uiuo, assuming that a circulating endogenous regulator of 
the sodium pump exists (de Lores  Arnaiz,  1993). 
Mutations found in the  H1 transmembrane domain have 
been found to decrease inhibition by ouabain. These include 
C113F and C113Y substitutions  in  the Xenopus lmuk first 
transmembrane domain (Canessa et al. 1992).  Likewise, the 
analogous changes C104A and C104F as well as Y108A con- 
ferred resistance in the sheep a1 enzyme (Shultheis and 
Lingrel, 1993). The  present T797N mutation is in the putative 
H5 transmembrane region.  While the transmembrane orga- 
nization of the a1 subunit is controversial, especially in  the 
carboxyl-terminal half of this enzyme, mutations in  trans- 
membrane domains that confer resistance to ouabain lend 
credence to  the possibility that  the lipophilic steroid nucleus 
of cardiac glycosides may bind in close proximity to  intra- 
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membrane residues. It also suggests that the interactions 
between ouabain and the sodium pump are more complex 
than previously reported. 
In summary, the present work indicates that Thr-797 plays 
a significant role in the interaction between ouabain and  the 
sodium  pump. These findings show that amino acids involved 
in ouabain inhibition are not limited to  the amino-terminal 
half of the sheep d-Na,K-ATPase but may  reside throughout 
the polypeptide. These findings also reflect the utility of 
random mutagenesis in the study of proteins whose three- 
dimensional structure by x-ray crystallography is not yet 
available. 
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